- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
688796
SHH
Week ended 07 Aug 2026
Weekly Investor Report
BIOCYTOGEN PHARMACEUTICALS (BEI · Healthcare · Biotechnology
Latest close
130.1 CNY
22.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 38.9% above the Trend Line and sits at 76.7% of its 52-week range. The latest completed week returned 22.3%, after a 15.8% four-week move. The latest news-sentiment score is 50/100.
Setup score
59
out of 100
Latest Close
130.1 CNY
7 Aug 2026
1W Return
22.3%
latest completed week
4W Return
15.8%
short-term follow-through
12W Return
35.3%
quarterly tape
Trend Breadth
14.7%
5 of 34 weeks active
Volume Ratio
1.4x
vs 13-week average
- 6 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
22.3%
Latest completed week; four-week move 15.8%.
Indicator stack
25/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 63.14%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 38.9% above the Trend Line and sits at 76.7% of its 52-week range. The latest completed week returned 22.3%, after a 15.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5912-week average 0.49
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.59Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers66 reversal markers
No recent accumulation markers. 6 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 15.8% over four weeks, 35.3% over 12 weeks, and - over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year5
Trend breadth14.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.38Latest activity-pressure read.
Pressure change2205.7%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.0%Distance below the 52-week high.
13-week volatility11.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher16 of 2610 weeks finished lower.
Best week+22.3%Week of 7 Aug.
Worst week-16.7%Week of 31 Jul.
Latest week+22.3%Week of 7 Aug.
Shape of recent returns
Strong gains11
Modest gains5
Flat weeks0
Modest losses5
Sharp losses5
Recent vol11.0%13-week weekly-return volatility.
Base vol9.7%52-week weekly-return volatility.
Up/down split22/11Count of positive and negative weeks in the 52-week window.
Average skew7.8% / -6.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank11 / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Biotechnology
4-week rank13 / 100
Group average4.5%
Trend breadth15.0%
Trend15.0%active weekly trend signals
MD37.0%positive activity pressure
RS32.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape53/100
Trend, activity pressure, participation, and risk combine to a 53/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 5/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.59; 6 reversal markers Next-Week ExpectancyPositive 63.14%Next-week expectancy is positive with a 63.14% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
ETFs Investing in Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class A Stocks Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 130.1 CNY | 22.3% | 93.67 CNY | 88.88 CNY | 0.38 | - | 14.7M | On |
| 31 Jul 2026 | 106.4 CNY | -16.7% | 91.09 CNY | 87.63 CNY | 0.36 | - | 19.9M | On |
| 24 Jul 2026 | 127.8 CNY | 9.2% | 89.24 CNY | 87.05 CNY | 0.31 | - | 18.3M | On |
| 17 Jul 2026 | 117.0 CNY | 4.1% | 86.65 CNY | 85.73 CNY | 0.13 | - | 19.8M | On |
| 10 Jul 2026 | 112.4 CNY | 1.1% | 84.69 CNY | 84.69 CNY | -0.02 | - | 12.7M | On |
| 3 Jul 2026 | 111.2 CNY | 20.7% | - | 83.74 CNY | -0.10 | - | 3.7M | Off |
| 26 Jun 2026 | 92.13 CNY | -2.1% | - | 82.76 CNY | - | - | 1.6M | Off |
| 19 Jun 2026 | 94.15 CNY | 5.7% | - | 82.41 CNY | - | - | 6.7M | Off |
| 12 Jun 2026 | 89.10 CNY | -5.0% | - | 81.96 CNY | - | - | 2.2M | Off |
| 5 Jun 2026 | 93.80 CNY | -14.4% | - | 81.67 CNY | - | - | 1.4M | Off |
| 29 May 2026 | 109.6 CNY | 4.9% | - | 81.17 CNY | - | - | 10.4M | Off |
| 22 May 2026 | 104.5 CNY | 8.7% | - | 79.93 CNY | - | - | 11.9M | Off |
| 15 May 2026 | 96.20 CNY | 0.7% | - | 78.81 CNY | - | - | 10.7M | Off |
| 8 May 2026 | 95.50 CNY | -0.9% | - | 77.99 CNY | - | - | 4.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.